Antihistamine Eye Drops, Compared: Ketotifen vs. Olopatadine vs. Azelastine

Oral antihistamines are decent at sneezes and mediocre at eyes. When allergy season hits the eyes directly, the itch, the watering, the grit, targeted allergy eye drops work faster and better, because the medicine lands exactly where the histamine is. The modern options all belong to one family: dual-action drops that block histamine and stabilize the mast cells that release it. Here's how the big three compare.

Ketotifen: the accessible workhorse

Over the counter, dosed every 8 to 12 hours. Ketotifen 0.025% (sold as Zaditor, Alaway, and cheap store generics) has been the OTC standard for years. It relieves itch within minutes, lasts most of a day on two doses, and the generic versions cost a few dollars a bottle. For occasional flare days and mild seasonal eyes, this is the sensible first stop.

Olopatadine: the once-a-day option

Over the counter since 2020, in three formulations with different schedules. Olopatadine (Pataday) moved from prescription to the pharmacy shelf as a product line, not a single drop: Pataday Twice Daily Relief (0.1%) is labeled twice daily, while Pataday Once Daily Relief (0.2%) and Once Daily Relief Extra Strength (0.7%) are labeled once daily. If remembering a midday dose is the reason your eyes are miserable by 3 pm, one of the once-daily formulations is the practical win. Check the box, because the brand name alone does not tell you the schedule. Pataday typically costs more than generic ketotifen.

Azelastine: the prescription-strength cousin

Available as an inexpensive prescription generic, dosed twice daily. Azelastine eye drops work in the same dual-action family and some patients simply respond better to one molecule than another. If OTC options underdeliver, asking a clinician about azelastine (or prescription-strength combinations) is the logical next rung. Fair warning shared by all three: a brief sting on instillation and a bitter taste at the back of the throat are the common quirks, azelastine especially.

Which brand is which: the name map

• Zaditor and Alaway are the same drug. Both are ketotifen 0.025%; so are the store generics next to them. Choose by price.
• Pataday and Patanol are both olopatadine. The current Pataday line has three strengths: Twice Daily Relief 0.1%, Once Daily Relief 0.2%, and Once Daily Relief Extra Strength 0.7% (once daily).
• Lastacaft is alcaftadine, once daily, over the counter since 2021.
• Azelastine eye drops are a prescription generic, no household brand on the shelf.
• Opcon-A and Naphcon-A combine an antihistamine (pheniramine) with a decongestant (naphazoline). The antihistamine half is legitimate; the decongestant half is why these are not for daily use.

Where does Lastacaft fit?

The newest shelf neighbor deserves a mention: alcaftadine (Lastacaft), over the counter since 2021, is a once-daily dual-action drop like olopatadine. Head to head, alcaftadine and olopatadine perform similarly on itch relief in comparative studies, and both out-last ketotifen's 8 to 12 hour window. Against Zaditor (ketotifen), Lastacaft's case is convenience: one drop in the morning instead of two doses a day, at a somewhat higher price. If daily dosing adherence is your weak point, either once-daily option beats a twice-daily drop you forget.

The head-to-heads people actually ask about

Azelastine vs. Pataday (olopatadine): both are dual-action antihistamine and mast-cell stabilizer drops, and head-to-head studies show comparable itch relief. The practical differences: azelastine is a prescription generic dosed twice daily and often costs less with insurance, while Pataday is over the counter in three formulations: the once-daily versions (0.2% and 0.7%) cover the day from one morning drop, and Twice Daily Relief (0.1%) matches azelastine’s schedule. Azelastine’s known quirk is a brief bitter taste as the drop drains through the tear duct; olopatadine users rarely report it.

Ketotifen vs. azelastine: the closest matchup on the list, both twice-daily dual-action drops with onset in minutes. Ketotifen (Zaditor, Alaway, store generics) wins on access, no prescription and often under $10. Some patients simply respond better to azelastine, and clinicians commonly try it when correctly used ketotifen is not controlling itch; that reflects practice patterns and individual response rather than proof that one molecule is stronger. Trying the OTC option first is the sensible order.

Olopatadine vs. Zaditor (ketotifen): the trade is dosing convenience versus price. Once-daily olopatadine costs more per bottle; twice-daily ketotifen costs less but fails when the second dose is forgotten. Efficacy per dose is similar enough that adherence, not chemistry, usually decides the winner.

Zaditor vs. Lastacaft: both are over the counter, and the trade mirrors the ketotifen-olopatadine matchup. Zaditor (ketotifen) is twice daily and cheap, with two decades of track record. Lastacaft (alcaftadine) is once daily, moved OTC in 2021, and in comparison studies performs at least as well on itch prevention. Pick Lastacaft if remembering a second dose is the failure point, Zaditor if price is; there is no wrong answer between them for most patients.

Pataday vs. azelastine at a glance

Because this is the matchup readers ask about most, here it is side by side. Whether you search for azelastine vs. Pataday or Pataday vs. azelastine, the comparison is the same: two dual-action drops with comparable itch relief, separated by dosing, access, and price.

The verdict most clinicians land on: convenience and no-prescription access favor Pataday, while a strong insurance plan and no objection to twice-daily dosing favor azelastine. Efficacy alone rarely settles it.

The one drop to avoid using daily

A caution that saves a lot of misery: "redness relief" decongestant drops (naphazoline, tetrahydrozoline) are not allergy treatment. They whiten eyes by constricting blood vessels, and within days of regular use they cause rebound redness that is worse than the original problem. They're for occasional cosmetic emergencies, never for daily allergy management.

Practical tips clinicians actually give

• Contacts out first. Labels for these drops say to remove lenses before instilling and wait at least 10 minutes before reinserting, because the preservative can absorb into soft lenses. Check your product's label.
• Store per the label, cool the eye separately. Most of these drops are labeled for room-temperature storage. For extra soothing, a clean cool compress over closed eyes works without involving the bottle.
• Artificial tears beforehand rinse pollen off the eye surface so the medicated drop works on the reaction, not the debris.
• Don't rub. Rubbing degranulates more mast cells and feeds the cycle. The drop works within minutes; give it the minutes.

One boundary worth stating plainly: eye pain, light sensitivity, vision changes, discharge, or symptoms that persist or worsen despite drops are reasons to see an eye-care professional, not to try a stronger bottle.

When drops stop being enough

If you're setting phone reminders for eye drops five months a year, every year, the drops are doing their job, but they cannot change what next season looks like. Itchy eyes are one output of an immune system that has misclassified pollen or dander as a threat, and for airborne allergies that underlying response is treatable with sublingual immunotherapy, with the goal that each season needs less managing than the last. In the U.S. this comes as FDA-approved under-the-tongue tablets for select allergens and as custom liquid drops prescribed off-label by clinicians; how allergy drops work covers that distinction honestly, and the cost guide covers the numbers.

Sources

• Alcon: Pataday product line: current formulations and labeled dosing (Twice Daily Relief 0.1%; Once Daily Relief 0.2%; Once Daily Relief Extra Strength 0.7%).
• DailyMed: Azelastine ophthalmic solution 0.05% label: twice-daily dosing, 10-minute contact-lens wait, and storage directions.

Frequently Asked Questions